David Cano-Martínez et al.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 19(8), 693-701 (2014-11-11)
Infliximab (IFX) is widely used in ulcerative colitis and in Crohn's disease treatment. Both diseases are characterised by increased oxidative stress, which may affect albumin oxidation. In order to test this hypothesis, the effect of IFX on colitis induced by